CEBP 09 AM Call for Abstracts w/deadline 09 AM Call for Abstracts w/deadline
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martinez, M. E.
Right arrow Articles by Alberts, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martinez, M. E.
Right arrow Articles by Alberts, D. S.

Cancer Epidemiology Biomarkers & Prevention, Vol 7, Issue 9 813-816, Copyright © 1998 by American Association for Cancer Research


ARTICLES

Design and baseline characteristics of study participants in the Wheat Bran Fiber trial

ME Martinez, ME Reid, J Guillen-Rodriguez, JR Marshall, R Sampliner, M Aickin, C Ritenbaugh, B van Leeuwen, N Mason-Liddil, A Giuliano, PA Vargas and DS Alberts
Arizona Cancer Center, University of Arizona Health Sciences Center, Tucson 85724, USA.

The Wheat Bran Fiber (WBF) trial is a Phase III clinical trial designed to assess the effect of a WBF intervention for 3 years on the recurrence of adenomatous polyps. Men and women, 40-80 years of age, who had removal of one or more colorectal adenoma(s) 3 mm or larger within 3 months prior to study entry were recruited from three sites in the Phoenix metropolitan area. After meeting eligibility criteria, 1509 individuals entered a 6-week run-in period, consisting of a low WBF (2 g/day) intervention. Participants (n = 1429) successfully completed this phase and were randomized to a high (13.5 g/day) or low (2 g/day) WBF intervention. Various data and specimens were collected at baseline and throughout the intervention phase, which included dietary intake, physical activity, other risk factor information, blood specimens, rectal biopsies, and polyp tissues. The study design called for a colonoscopy at approximately 1 year after the qualifying colonoscopy; thus, the period between the first year and the final colonoscopy will be used to assess the effect of the intervention, which is expected to be completed in the latter part of 1998.


This article has been cited by other articles:


Home page
Cancer Res.Home page
J. B. Egan, E. T. Jacobs, M. E. Martinez, E. W. Gerner, P. W. Jurutka, and P. A. Thompson
Presence of a TA Haplotype in the APC Gene Containing the Common 1822 Polymorphism and Colorectal Adenoma
Cancer Res., July 15, 2008; 68(14): 6006 - 6013.
[Abstract] [Full Text] [PDF]


Home page
Stat Methods Med ResHome page
C.-H. Hsu
A weighted zero-inflated Poisson model for estimation of recurrence of adenomas
Statistical Methods in Medical Research, April 1, 2007; 16(2): 155 - 166.
[PDF]


Home page
Am. J. Clin. Nutr.Home page
E. T Jacobs, E. Lanza, D. S Alberts, C.-H. Hsu, R. Jiang, A. Schatzkin, P. A Thompson, and M. E. Martinez
Fiber, sex, and colorectal adenoma: results of a pooled analysis
Am. J. Clinical Nutrition, February 1, 2006; 83(2): 343 - 349.
[Abstract] [Full Text] [PDF]


Home page
Statistical ModellingHome page
C.-H. Hsu
Joint modelling of recurrence and progression of adenomas: a latent variable approach
Statistical Modeling, October 1, 2005; 5(3): 201 - 215.
[Abstract] [PDF]


Home page
JNCI J Natl Cancer InstHome page
D. S. Alberts, M. E. Martinez, L. M. Hess, J. G. Einspahr, S. B. Green, A. K. Bhattacharyya, J. Guillen, M. Krutzsch, A. K. Batta, G. Salen, et al.
Phase III Trial of Ursodeoxycholic Acid To Prevent Colorectal Adenoma Recurrence
J Natl Cancer Inst, June 1, 2005; 97(11): 846 - 853.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
E. T. Jacobs, R. Jiang, D. S. Alberts, E. R. Greenberg, E. W. Gunter, M. R. Karagas, E. Lanza, L. Ratnasinghe, M. E. Reid, A. Schatzkin, et al.
Selenium and Colorectal Adenoma: Results of a Pooled Analysis
J Natl Cancer Inst, November 17, 2004; 96(22): 1669 - 1675.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. E. Martinez, S. M Henning, and D. S Alberts
Folate and colorectal neoplasia: relation between plasma and dietary markers of folate and adenoma recurrence
Am. J. Clinical Nutrition, April 1, 2004; 79(4): 691 - 697.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. E. Reid, J. R. Marshall, D. Roe, M. Lebowitz, D. Alberts, A. K. Battacharyya, and M. E. Martinez
Smoking Exposure as a Risk Factor for Prevalent and Recurrent Colorectal Adenomas
Cancer Epidemiol. Biomarkers Prev., October 1, 2003; 12(10): 1006 - 1011.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. E. Martinez, T. G. O'Brien, K. E. Fultz, N. Babbar, H. Yerushalmi, N. Qu, Y. Guo, D. Boorman, J. Einspahr, D. S. Alberts, et al.
Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase gene
PNAS, June 24, 2003; 100(13): 7859 - 7864.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
D. S. Alberts, J. G. Einspahr, D. L. Earnest, M. F. Krutzsch, P. Lin, L. M. Hess, D. K. Heddens, D. J. Roe, M. E. Martinez, G. Salen, et al.
Fecal Bile Acid Concentrations in a Subpopulation of the Wheat Bran Fiber Colon Polyp Trial
Cancer Epidemiol. Biomarkers Prev., March 1, 2003; 12(3): 197 - 200.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
E. T. Jacobs, A. R. Giuliano, D. J. Roe, J. M. Guillen-Rodriguez, D. S. Alberts, and M. E. Martinez
Baseline Dietary Fiber Intake and Colorectal Adenoma Recurrence in the Wheat Bran Fiber Randomized Trial
J Natl Cancer Inst, November 6, 2002; 94(21): 1620 - 1625.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
E. T. Jacobs, A. R. Giuliano, D. J. Roe, J. M. Guillen-Rodriguez, L. M. Hess, D. S. Alberts, and M. E. Martinez
Intake of Supplemental and Total Fiber and Risk of Colorectal Adenoma Recurrence in the Wheat Bran Fiber Trial
Cancer Epidemiol. Biomarkers Prev., September 1, 2002; 11(9): 906 - 914.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
D. S. Alberts, M. E. Martinez, D. J. Roe, J. M. Guillen-Rodriguez, J. R. Marshall, J. B. van Leeuwen, M. E. Reid, C. Ritenbaugh, P. A. Vargas, A.B. Bhattacharyya, et al.
Lack of Effect of a High-Fiber Cereal Supplement on the Recurrence of Colorectal Adenomas
N. Engl. J. Med., April 20, 2000; 342(16): 1156 - 1162.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. E. Martínez, J. R. Marshall, E. Graver, R. C. Whitacre, K. Woolf, C. Ritenbaugh, and D. S. Alberts
Reliability and Validity of a Self-Administered Food Frequency Questionnaire in a Chemoprevention Trial of Adenoma Recurrence
Cancer Epidemiol. Biomarkers Prev., October 1, 1999; 8(10): 941 - 946.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
M. E. Martinez, T. Maltzman, J. R. Marshall, J. Einspahr, M. E. Reid, R. Sampliner, D. J. Ahnen, S. R. Hamilton, and D. S. Alberts
Risk Factors for Ki-ras Protooncogene Mutation in Sporadic Colorectal Adenomas
Cancer Res., October 1, 1999; 59(20): 5181 - 5185.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1998 by the American Association for Cancer Research.